Enteritis necroticans ?pigbel? in a Japanese diabetic adult

2007 ◽  
Vol 57 (9) ◽  
pp. 622-626 ◽  
Author(s):  
Tomomichi Matsuda ◽  
Yuji Okada ◽  
Eiji Inagi ◽  
Yasushi Tanabe ◽  
Yozo Shimizu ◽  
...  
1952 ◽  
Vol 21 (1) ◽  
pp. 110-118 ◽  
Author(s):  
Marcel Patterson ◽  
Harold D. Rosenbaum

2019 ◽  
Vol 51 (4) ◽  
pp. 333-334
Author(s):  
Bjoern Zante ◽  
Pascale Tinguley ◽  
Daniel Ott ◽  
Matthias Dettmer ◽  
Beat Gloor ◽  
...  

Vaccines ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 17 ◽  
Author(s):  
Jing Bai ◽  
Xinyuan Qiao ◽  
Yingying Ma ◽  
Meijing Han ◽  
Shuo Jia ◽  
...  

Clostridium perfringens is an opportunistic pathogen. Its main virulence factors are exotoxins, which are the etiological agents of enteritis necroticans and enterotoxemia caused in livestock (cattle, sheep, and rabbits). Here, we demonstrated effective immune protection for rabbits against α, β, and ε exotoxins of C. perfringens provided by an oral tetravalent bait probiotic vaccine delivering α, ε, β1, and β2 toxoids of C. perfringens. Results showed that the recombinant probiotic had good segregational stability and good colonization ability in the rabbit intestinal tract. Oral administration of the probiotic vaccine can effectively elicit significant levels of antigen-specific mucosa sIgA and sera IgG antibodies with exotoxin-neutralizing activity. Additionally, oral immunization with the probiotic vaccine effectively promoted lymphoproliferation and Th1/Th2-associated cytokine production. The protection rate of immunized rabbits with the probiotic vaccine was 80% after challenging rabbits with a combination of C. perfringens (toxinotypes A, C, and D) and exotoxin mixture, which was better than the 60% provided by a commercial inactivated C. perfringens A, C, and D trivalent vaccine. Moreover, obvious histopathological changes were observed in the intestinal tissues of rabbits in the commercial vaccine and PBS groups. The bait probiotic vaccine can provide effective protection against C. perfringens exotoxins, suggesting a promising C. perfringens vaccination strategy.


1967 ◽  
Vol 71 (2) ◽  
pp. 264-268 ◽  
Author(s):  
D.H. Wright ◽  
J.P. Stanfield

1980 ◽  
Vol 13 (3) ◽  
pp. 445-450 ◽  
Author(s):  
P. D. Walker ◽  
T. G. C. Murrell ◽  
L. K. Nagy

Sign in / Sign up

Export Citation Format

Share Document